Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemo-brain”

316 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 316 results

Testing effectiveness (Phase 2)Study completedNCT00002619
What this trial is testing

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health 60
Large-scale testing (Phase 3)Study completedNCT00002875
What this trial is testing

Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma

Who this might be right for
Brain TumorsCentral Nervous System Tumors
Children's Oncology Group 421
Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT02290834
What this trial is testing

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

Who this might be right for
Impaired CognitionChemo-brainBreast Cancer
Massachusetts General Hospital 200
Not applicableLooking for participantsNCT06140875
What this trial is testing

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)

Who this might be right for
Glioblastoma
Charite University, Berlin, Germany 26
Early research (Phase 1)Looking for participantsNCT07179328
What this trial is testing

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Who this might be right for
GBMGlioblastoma Multiforme (GBM)Glioblastoma Multiforme of Brain+5 more
Sunnybrook Health Sciences Centre 10
Large-scale testing (Phase 3)Active Not RecruitingNCT05902169
What this trial is testing

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Who this might be right for
GlioblastomaRecurrent GlioblastomaGBM
CarThera 560
Testing effectiveness (Phase 2)Active Not RecruitingNCT05012254
What this trial is testing

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases, AdultLung Cancer
Fundación GECP 71
Not applicableStudy completedNCT02457039
What this trial is testing

Acupuncture Prevents Chemobrain in Breast Cancer Patients

Who this might be right for
Chemo-brainDrug-Related Side Effects and Adverse ReactionsMild Cognitive Impairment+1 more
The University of Hong Kong 93
Not applicableStudy completedNCT02250755
What this trial is testing

MRI Perfusion on T1 and T2 Brain Lesion(s)

Who this might be right for
Lung Carcinoma Metastatic to the Brain
University Hospital, Lille 30
Large-scale testing (Phase 3)Ended earlyNCT01507506
What this trial is testing

Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma

Who this might be right for
Glioblastoma
Institut Claudius Regaud 180
Testing effectiveness (Phase 2)Study completedNCT01295944
What this trial is testing

Carboplatin and Bevacizumab for Recurrent Ependymoma

Who this might be right for
EpendymomaAnaplastic Ependymoma
National Cancer Institute (NCI) 35
Not applicableEnded earlyNCT02580045
What this trial is testing

Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer

Who this might be right for
Metastatic Cancer Patients on an Anti-cancer TherapyAdvanced CancerBrain Metastasis
Duke University 3
Large-scale testing (Phase 3)Ended earlyNCT01014767
What this trial is testing

Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors

Who this might be right for
Brain CancerChoroid Plexus Tumors
Tufts Medical Center 27
Not applicableStudy completedNCT00416819
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
University of California, San Francisco 10
Testing effectiveness (Phase 2)UnknownNCT04333004
What this trial is testing

Analysis of Gut Microbiota in Patients With Brain Metastasis of Non-small Cell Lung Cancer Treated by Pembrolizumab Combined With Chemotherapy

Who this might be right for
Gut MicrobiotaNSCLCPembrolizumab+1 more
Xiaorong Dong 40
Early research (Phase 1)Study completedNCT04842513
What this trial is testing

Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
University Hospital Tuebingen 15
Testing effectiveness (Phase 2)UnknownNCT01342237
What this trial is testing

Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors

Who this might be right for
Brain Tumors
Seoul National University Hospital 33
Early research (Phase 1)Study completedNCT01688401
What this trial is testing

Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG).

Who this might be right for
Diffuse Intrinsic Pontine Glioma (DIPG)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07365410
What this trial is testing

Furmonertinib 160mg vs 80mg + Chemotherapy in EGFR-Mutated NSCLC With Brain Metastases: Efficacy and Safety Study

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Brain MetastasesFurmonertinib+1 more
Tianjin Medical University Cancer Institute and Hospital 60
Load More Results